u Occult Adrenal Insufficiency in Renal Amyloidosis Patients

dc.authorid0000-0003-3122-5491
dc.contributor.authorTurgut, Didem
dc.contributor.authorPiskinpasa, Serhan Vahit
dc.contributor.authorKeskin, Havva
dc.contributor.authorAgbaht, Kemal
dc.contributor.authorYenigun, Ezgi Coskun
dc.contributor.authorDede, Fatih
dc.date.accessioned2025-05-10T19:52:46Z
dc.date.issued2021
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractObjective: Systemic amyloidosis may affect many organs, and may cause endocrinologic problems which may result in adrenal insufficiency. However, assessment of adrenocortical reserve is challenging in amyloidosis patients with renal involvement. We aimed to evaluate adrenocortical reserve with various methods of cortisol measurement to determine any occult clinical condition. Methods: Patients with renal amyloidosis and healthy subjects were evaluated in this cross-sectional study. Basal cortisol, corticosteroid-binding globulin (CBG), and albumin levels were measured. Serum free cortisol (cFC) level was calculated. Cortisol response tests performed after ACTH stimulation test (250 mu g, intravenously) were evaluated, and free cortisol index (FCI) was calculated. Results: Twenty renal amyloidosis patients, and 25 healthy control subjects were included in the study. Patients and control subjects had similar median serum baseline cortisol levels [258 (126-423) vs 350 (314-391) nmol/L, p=0.169)] whereas patients' stimulated cortisol levels at the 60th minute were lower [624 (497-685) vs 743 (674-781) nmol/L, p=0.011)]. The 60th-minute total cortisol levels of 8 of the 20 (40%) amyloidosis patients were <500 nmol/L, but only three of these 8 patients had stimulated FCI <12 nmol/mg suggesting an adrenal insufficiency (15%). Conclusion: ACTH stimulation test and cortisol measurements should be considered in renal amyloidosis patients with severe proteinuria to avoid false positive results if only ACTH stimulation test is used. It will be appropriate to evaluate this group of patients together with estimated measurements as FCI.
dc.identifier.doi10.5222/MMJ.2021.93902
dc.identifier.endpage57
dc.identifier.issn2149-2042
dc.identifier.issn2149-4606
dc.identifier.issue1
dc.identifier.pmid33828890
dc.identifier.scopus2-s2.0-85103409516
dc.identifier.scopusqualityQ2
dc.identifier.startpage52
dc.identifier.trdizinid417880
dc.identifier.urihttps://doi.org/10.5222/MMJ.2021.93902
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/417880
dc.identifier.urihttps://hdl.handle.net/20.500.14730/12534
dc.identifier.volume36
dc.identifier.wosWOS:001109445100004
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherGalenos Publ House
dc.relation.ispartofMedeniyet Medical Journal
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250302
dc.subjectAdrenocorticalinsufficiency
dc.subjectalbumin
dc.subjectCBG
dc.subjectcortisol
dc.subjectrenal amyloidosis
dc.titleu Occult Adrenal Insufficiency in Renal Amyloidosis Patients
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
12533.pdf
Boyut:
148.59 KB
Biçim:
Adobe Portable Document Format